SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-109128
Filing Date
2023-10-13
Accepted
2023-10-13 16:42:07
Documents
14
Period of Report
2023-10-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2328392d1_8k.htm   iXBRL 8-K 28779
2 EXHIBIT 4.1 tm2328392d1_4-1.htm EX-4.1 99003
3 EXHIBIT 10.1 tm2328392d1_10-1.htm EX-10.1 126616
  Complete submission text file 0001104659-23-109128.txt   489075

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA aplt-20231012.xsd EX-101.SCH 3048
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE aplt-20231012_lab.xml EX-101.LAB 34240
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aplt-20231012_pre.xml EX-101.PRE 22381
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2328392d1_8k_htm.xml XML 3386
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38898 | Film No.: 231325460
SIC: 2834 Pharmaceutical Preparations